Delhi Pharmaceutical Science and Research University

-

The Pharmaceutical University which has been a long pending plan of the Delhi government is going to be functional from this academic session.

The Act of Delhi Pharmaceutical Science and Research University (DPSRU) was passed by the Legislative Assembly of National Capital Territory of Delhi in September, 2008 but it could not be made functional, so far.

“With the vision to promote excellence, research and development in pharmaceutical field the new Government of Delhi took initiative by making the University functional,” an official from the Delhi government said.

The Board of Governors (BoG) of the University has been notified to take forward the academic functioning of the University from the Current Academic Session 2015-16.

The University will run from the DIPSAR Campus at Pushp Vihar in Saket. Presently, the existing institute DIPSAR is running Diploma, Bachelor Degree and Master Degree in Pharmacy.

The University will introduce more courses in pharmaceutical field and in allied sciences, like medical lab technology and physiotherapy. This will increase the present student strength of around 600 to 1,500 over a period of three years. More specialised Post Graduate Programmes will also be added along with creation of Centres of Excellence in the specialised area of pharmacy like medicinal chemistry, toxicology, drug regulatory affairs.

The University will also focus on the thrust area of research like diabetes mellitus, biological research, drug discovery and development and herbal drug technology etc.
The creation of University will boost the pharmaceutical and health care industries that the University will collaborate and share the research and development as per requirements of the industry.

http://www.thehindu.com/news/national/other-states/pharmaceutical-university-opens-from-this-academic-session/article7462328.ece

Comments

Post a Comment

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

-
The China-India joint summit held recently discussed bilateral trade to improve Indo- China pharma industry and address issues like long product registration time and high fees for product registration in China’s drug regulatory system, among other issues.  Besides this, other relevant key issues related to transparency in public procurement system in China and clinical trial related approvals were also deliberated at the summit organised under the aegis of Indian Pharmaceutical Association (IPA), Shengjie and SaSPinjara, China between May 16 and May 17, 2019 at Pullman Shanghai South, China. The summit was focused on enhancing export business for both the nations across the globe. Senior health ministry official from Government of Gujarat Punamchand Parmar was invited as the Chief Guest of the summit and Gujarat Food and Drugs Control Administration (FDCA) Commissioner Dr Hemant Koshia was invited as Guest of Honour.  Among other dignitaries, Dr. Anil Kumar Rai, Consulate General of
Read more

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

-
Image
“IDEA TO MARKET” is an idea hunt to commercialize the herbal inventions. It is a platform for researchers to use their innovative ideas in the area of herbal research and get the products commercialized in collaboration with corporate partners.  Hurry up and register for the webinar to know more about this program. The webinar is organized by Bombay College of Pharmacy and Pharma Literati.  Registration Link for webinar on OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH: https://docs.google.com/forms/d/e/1FAIpQLSfUhe1LtCOjG50SilFw_iECnzBXu4CW0nK2wIvd8QVVvpDOzQ/viewform
Read more